1. Home
  2. BIO vs HSIC Comparison

BIO vs HSIC Comparison

Compare BIO & HSIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIO
  • HSIC
  • Stock Information
  • Founded
  • BIO 1952
  • HSIC 1932
  • Country
  • BIO United States
  • HSIC United States
  • Employees
  • BIO N/A
  • HSIC N/A
  • Industry
  • BIO Biotechnology: Laboratory Analytical Instruments
  • HSIC Medical Specialities
  • Sector
  • BIO Industrials
  • HSIC Health Care
  • Exchange
  • BIO Nasdaq
  • HSIC Nasdaq
  • Market Cap
  • BIO 6.0B
  • HSIC 9.0B
  • IPO Year
  • BIO N/A
  • HSIC 1995
  • Fundamental
  • Price
  • BIO $243.98
  • HSIC $73.50
  • Analyst Decision
  • BIO Strong Buy
  • HSIC Buy
  • Analyst Count
  • BIO 4
  • HSIC 10
  • Target Price
  • BIO $324.25
  • HSIC $79.30
  • AVG Volume (30 Days)
  • BIO 417.7K
  • HSIC 1.6M
  • Earning Date
  • BIO 07-31-2025
  • HSIC 08-05-2025
  • Dividend Yield
  • BIO N/A
  • HSIC N/A
  • EPS Growth
  • BIO N/A
  • HSIC 8.11
  • EPS
  • BIO N/A
  • HSIC 3.21
  • Revenue
  • BIO $2,541,100,000.00
  • HSIC $12,669,000,000.00
  • Revenue This Year
  • BIO N/A
  • HSIC $4.28
  • Revenue Next Year
  • BIO $3.49
  • HSIC $3.57
  • P/E Ratio
  • BIO N/A
  • HSIC $22.83
  • Revenue Growth
  • BIO N/A
  • HSIC 1.75
  • 52 Week Low
  • BIO $211.43
  • HSIC $60.56
  • 52 Week High
  • BIO $387.99
  • HSIC $82.49
  • Technical
  • Relative Strength Index (RSI)
  • BIO 60.94
  • HSIC 64.32
  • Support Level
  • BIO $235.01
  • HSIC $72.89
  • Resistance Level
  • BIO $246.50
  • HSIC $73.88
  • Average True Range (ATR)
  • BIO 7.17
  • HSIC 1.28
  • MACD
  • BIO 2.32
  • HSIC 0.17
  • Stochastic Oscillator
  • BIO 90.49
  • HSIC 89.74

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

About HSIC Henry Schein Inc.

Henry Schein Inc is a solutions company for healthcare professionals powered by a network of people and technology. The company is a provider of healthcare products and services to office-based dental and medical practitioners, as well as alternate sites of care. The company's reportable segments are global Distribution and Value-Added Services; global Specialty Products; and global Technology. It generates the majority of its revenue from the global Distribution and Value-Added Services segment which includes distribution to the global dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services.

Share on Social Networks: